Bayer Healthcare announced that the FDA has accepted its New Drug Application (NDA) for filing and has granted priority review of Radium Ra 223 Dichloride (radium-223) for the treatment of ...

Oslo, Norway, 15 November 2013 - Algeta ASA (OSE: ALGETA) announces today that Bayer has received marketing authorisation from the European Commission for Xofigo ® (radium Ra 223 dichloride) solution ...

U.S. FDA Grants Priority Review to Bayer's Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases WAYNE, N.J., Feb. 13, 2013 /PRNewswire/ -- Bayer HealthCare ...

Bayer Submits New Drug Application for Radium Ra 223 Dichloride for the Treatment of Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases WAYNE, N.J., Dec. 14, 2012 /PRNewswire via COMTEX/ ...

Oslo, Norway, 20 June 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of its commercial production ...

(MENAFN- Market Press Release) March 29, 2025 4:01 am - Brazil, India, and Indonesia are the fastest growing demand hubs within the $459.1 million Radium Ra 223 Dichloride market and expected to grow ...

Characterization of aggressive interventions within 30 days of death in lung cancer patients at Smilow Cancer Hospital (SCH). This is an ASCO Meeting Abstract from the 2014 Quality Care Symposium.

CASE-history data are presented on 12 women who have carried in their skeletons for many years toxicologically interesting burdens of the radioisotopes Ra 226 (radium, or Ra) and Ra 228 (mesothorium, ...

Curious Kids is a series for children of all ages. If you have a question you’d like an expert to answer, send it to ...

Using lasers with precisely tuned frequency, λ, physicists control rotational states of radium monofluoride molecules and excite specific rotational levels, characterized by the quantum number, J.